NOTE 5 – ACCOUNTS PAYABLE

12 Months Ended

Mar. 31, 2024

Payables and Accruals [Abstract]

NOTE 5 – ACCOUNTS PAYABLE

NOTE 5 – ACCOUNTS PAYABLE

Accounts payable consisted of the following at March 31, 2024 and March 31, 2023:

	March 31, 2024		March 31, 2023
Accounting and audit	$	181,955	$	149,613
Legal fees and transfer agent		85,627		59,565
Research and development		409,904		337,893
General and administrative		147,724		66,658
Total Accrued Expenses	$	825,210	$	613,729

ALTEROLA BIOTECH, INC.

NOTES TO THE UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS

MARCH 31, 2024